malignant pleural effusion

The prognosis for patients with malignant pleural effusions is often measured in weeks.

For patients with malignant pleural effusions, it allows them to continue chemotherapy, if indicated.

The following symptoms may be caused by malignant pleural effusion:

Treatment of the symptoms of malignant pleural effusion may include the following:

Lung cancer and breast cancer account for about 50-65% of malignant pleural effusions.

Common symptoms associated with malignant pleural effusions include dyspnea, cough, and chest discomfort.

The goal of treatment of malignant pleural effusions is relief of breathlessness.

Cell line UKY-104 is an adenocarcinoma established in primary culture from a malignant pleural effusion.

Pleural carcinosis is associated with malignant pleural effusion and poor prognosis.

Tattersall M: Management of malignant pleural effusion.

Malignant pleural effusion.

Malignant pleural effusions often occur in advanced or unresectable cancer or in the last few weeks of life.

Malignant pleural effusions are exudates.

Patients with T4 disease caused by malignant pleural effusions are treated similarly to patients with stage 4 disease.

Clinical factors predicting the diagnosis of malignant pleural effusions are symptoms lasting more than 1 month and the absence of fever.

This drug was discontinued after 3 mo when she developed a new left-sided malignant pleural effusion (Figure S1C, middle panel).

Mesothelioma and primary lung cancers can spread through the pleural cavity, often causing malignant pleural effusion.

The management of a malignant pleural effusion is different from the management of a nonmalignant effusion, so an accurate diagnosis is important.

H. cordata injection, a traditional Chinese medicine, is often used to relieve abnormal lung symptoms, infectious disease, refractory hemoptysis and malignant pleural effusion in China.

Malignant pleural effusions are a common complication of malignancy, and malignancy is a common cause of pleural effusions in general.

Identification of pleural fluid biomarkers to distinguish malignant pleural effusions from other causes of exudative effusions would help diagnosis.

Emad A, Rezaian GR: Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline.

Important cardiopulmonary syndromes include malignant pleural effusion, malignant pericardial effusion, superior vena cava syndrome, and lymphangitic carcinomatosis.

Check NCI's list of cancer clinical trials for U.S. supportive and palliative care trials about malignant pleural effusion that are now accepting participants.

Tremblay A, Michaud G: Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.